Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection
Article Sidebar
Main Article Content
Abstract
Background: Circulating degranulated platelets have been described during acute SARS-CoV-2 infection and associated with COVID-19 complications. This study investigated the relationship between the presence of plasma SARS-CoV-2 RNA (ie, SARS-CoV-2 RNAemia), systemic
inflammation, and platelet dysfunction in a group of patients with COVID-19. Unlike our previous publication, which focused on platelet characterization, this work explores potential determinants of platelet activation, based on a distinct subset of patients with available stored samples.
Methods: Patients with COVID-19 were stratified by platelet δ-granule content using the luciferin/luciferase assay into 2 groups: normal (COVδ-norm) and low (COVδ-low). Plasma SARS-CoV-2 RNAemia (RT-qPCR), cytokines, and chemokines (Cytometric Bead Array) were quantified on plasma samples. Markers of platelet activation were measured by flow cytometry in whole blood.
Results: A total of 75 patients with COVID-19 were enrolled; 57 presented normal levels of platelet δ-granule content (COVδ-norm) and 18 had low levels of platelet δ-granules (COVδ-low). Groups were comparable in terms of age, sex, comorbidities, and SARS-CoV-2 RNAemia levels. Patients in the COVδ-low group showed significantly higher chemokine and cytokine levels compared to those in the COVδ-norm group, with strong correlations between IL-6, as well as granulocyte-macrophage colony-stimulating factor (GM-CSF), with platelet degranulation parameters. A similar trend, albeit less pronounced, was observed when patients were stratified based on their platelet activation phenotype.
Conclusions: These findings suggest that peripheral inflammation, rather than SARS-CoV-2 RNAemia, is associated with platelet dysfunction during acute SARS-CoV-2 infection.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for C. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. Epub 20200228. doi: 10.1056/NEJMoa2002032. PubMed PMID: 32109013; PMCID: PMC7092819.
2. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: 10.1001/jama.2020.2648. PubMed PMID: 32091533.
3. Thomas MR, Scully M. Clinical features of thrombosis and bleeding in COVID-19. Blood. 2022;140(3):184-95. doi: 10.1182/blood.2021012247. PubMed PMID: 35452509; PMCID: PMC9040438.
4. Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, Thursz M, Manousou P, Corbett R, Goldin R, Al-Sarraj S, Abdolrasouli A, Swann OC, Baillon L, Penn R, Barclay WS, Viola P, Osborn M. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245-e53. Epub 20200820. doi: 10.1016/S2666-5247(20)30115-4. PubMed PMID: 32844161; PMCID: PMC7440861.
5. Musoke N, Lo KB, Albano J, Peterson E, Bhargav R, Gul F, DeJoy R, 3rd, Salacup G, Pelayo J, Tipparaju P, Azmaiparashvili Z, Patarroyo-Aponte G, Rangaswami J. Anticoagulation and bleeding risk in patients with COVID-19. Thromb Res. 2020;196:227-30. Epub 20200824. doi: 10.1016/j.thromres.2020.08.035. PubMed PMID: 32916565; PMCID: PMC7444469.
6. Barrett TJ, Lee AH, Xia Y, Lin LH, Black M, Cotzia P, Hochman J, Berger JS. Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease. Circ Res. 2020;127(7):945-7. Epub 20200806. doi: 10.1161/CIRCRESAHA.120.317803. PubMed PMID: 32757722; PMCID: PMC7478197.
7. Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, Pao CRR, Righy C, Franco S, Souza TML, Kurtz P, Bozza FA, Bozza PT. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136(11):1330-41. doi: 10.1182/blood.2020007252. PubMed PMID: 32678428; PMCID: PMC7483437.
8. Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M, Weyrich AS, Yost CC, Rondina MT, Campbell RA. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317-29. doi: 10.1182/blood.2020007214. PubMed PMID: 32573711; PMCID: PMC7483430.
9. Scavone M, Ghali C, Calogiuri M, Sala M, Bossi E, Mencarini T, Bozzi S, Clerici B, Birocchi S, Fioretti A, Bono V, Maugeri N, Marchetti G, Cattaneo M, Podda GM. Impairment of platelet function in both mild and severe COVID-19 patients. Br J Haematol. 2023;203(4):656-67. Epub 20230824. doi: 10.1111/bjh.19062. PubMed PMID: 37615207.
10. Lindner D, Fitzek A, Brauninger H, Aleshcheva G, Edler C, Meissner K, Scherschel K, Kirchhof P, Escher F, Schultheiss HP, Blankenberg S, Puschel K, Westermann D. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020;5(11):1281-5. doi: 10.1001/jamacardio.2020.3551. PubMed PMID: 32730555; PMCID: PMC7385672.
11. Qian Q, Fan L, Liu W, Li J, Yue J, Wang M, Ke X, Yin Y, Chen Q, Jiang C. Direct Evidence of Active SARS-CoV-2 Replication in the Intestine. Clin Infect Dis. 2021;73(3):361-6. doi: 10.1093/cid/ciaa925. PubMed PMID: 32638022; PMCID: PMC7454471.
12. Xiang Q, Feng Z, Diao B, Tu C, Qiao Q, Yang H, Zhang Y, Wang G, Wang H, Wang C, Liu L, Wang C, Liu L, Chen R, Wu Y, Chen Y. SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs. Front Immunol. 2021;12:661052. Epub 20210428. doi: 10.3389/fimmu.2021.661052. PubMed PMID: 33995382; PMCID: PMC8113960.
13. Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, Braun F, Lu S, Pfefferle S, Schroder AS, Edler C, Gross O, Glatzel M, Wichmann D, Wiech T, Kluge S, Pueschel K, Aepfelbacher M, Huber TB. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590-2. Epub 20200513. doi: 10.1056/NEJMc2011400. PubMed PMID: 32402155; PMCID: PMC7240771.
14. Rovito R, Bono V, Augello M, Tincati C, Mainoldi F, Beaudoin-Bussieres G, Tauzin A, Bianchi S, Hadla M, Yellenki V, d’Arminio Monforte A, Casola S, Borghi E, Finzi A, Marchetti G. Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients. Sci Rep. 2022;12(1):19658. Epub 20221116. doi: 10.1038/s41598-022-23923-1. PubMed PMID: 36385627; PMCID: PMC9667450.
15. Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ, Massachusetts Consortium for Pathogen R. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493. Epub 20201030. doi: 10.1038/s41467-020-19057-5. PubMed PMID: 33127906; PMCID: PMC7603483.
16. Brunet-Ratnasingham E, Anand SP, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, Beaudoin-Bussieres G, Pagliuzza A, Gasser R, Benlarbi M, Point F, Prevost J, Laumaea A, Niessl J, Nayrac M, Sannier G, Orban C, Messier-Peet M, Butler-Laporte G, Morrison DR, Zhou S, Nakanishi T, Boutin M, Descoteaux-Dinelle J, Gendron-Lepage G, Goyette G, Bourassa C, Medjahed H, Laurent L, Rebillard RM, Richard J, Dube M, Fromentin R, Arbour N, Prat A, Larochelle C, Durand M, Richards JB, Chasse M, Tetreault M, Chomont N, Finzi A, Kaufmann DE. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. Sci Adv. 2021;7(48):eabj5629. Epub 20211126. doi: 10.1126/sciadv.abj5629. PubMed PMID: 34826237; PMCID: PMC8626074.
17. Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, Ding J, Li F. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020;71(8):1937-42. doi: 10.1093/cid/ciaa449. PubMed PMID: 32301997; PMCID: PMC7184354.
18. Li Y, Schneider AM, Mehta A, Sade-Feldman M, Kays KR, Gentili M, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilly BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Parry BA, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Regan J, Flynn JP, Villani AC, Hacohen N, Goldberg MB, Filbin MR, Li JZ. SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 Outcomes. medRxiv. 2021. Epub 20210226. doi: 10.1101/2021.02.24.21252357. PubMed PMID: 33655257; PMCID: PMC7924277.
19. Rodriguez-Serrano DA, Roy-Vallejo E, Zurita Cruz ND, Martin Ramirez A, Rodriguez-Garcia SC, Arevalillo-Fernandez N, Galvan-Roman JM, Fontan Garcia-Rodrigo L, Vega-Piris L, Chicot Llano M, Arribas Mendez D, Gonzalez de Marcos B, Hernando Santos J, Sanchez Azofra A, Avalos Perez-Urria E, Rodriguez-Cortes P, Esparcia L, Marcos-Jimenez A, Sanchez-Alonso S, Llorente I, Soriano J, Suarez Fernandez C, Garcia-Vicuna R, Ancochea J, Sanz J, Munoz-Calleja C, de la Camara R, Canabal Berlanga A, Gonzalez-Alvaro I, Cardenoso L, Group R-C. Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients. Sci Rep. 2021;11(1):13134. Epub 20210623. doi: 10.1038/s41598-021-92497-1. PubMed PMID: 34162948; PMCID: PMC8222315.
20. Perumal R, Shunmugam L, Naidoo K, Wilkins D, Garzino-Demo A, Brechot C, Vahlne A, Nikolich J. Biological mechanisms underpinning the development of long COVID. iScience. 2023;26(6):106935. Epub 20230518. doi: 10.1016/j.isci.2023.106935. PubMed PMID: 37265584; PMCID: PMC10193768.
21. Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El Haj R, Mahir W, Belayachi L, Belefquih B, Benouda A, Cheikh A, Langlois MA, Cherrah Y, Flamand L, Guessous F, Boilard E. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19. Circ Res. 2020;127(11):1404-18. Epub 20200917. doi: 10.1161/CIRCRESAHA.120.317703. PubMed PMID: 32938299; PMCID: PMC7641188.
22. Zhu A, Real F, Capron C, Rosenberg AR, Silvin A, Dunsmore G, Zhu J, Cottoignies-Callamarte A, Masse JM, Moine P, Bessis S, Godement M, Geri G, Chiche JD, Valdebenito S, Belouzard S, Dubuisson J, Lorin de la Grandmaison G, Chevret S, Ginhoux F, Eugenin EA, Annane D, Borde EC, Bomsel M. Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19. Cell Mol Life Sci. 2022;79(7):365. Epub 20220616. doi: 10.1007/s00018-022-04318-x. PubMed PMID: 35708858; PMCID: PMC9201269.
23. Campbell RA, Schwertz H, Hottz ED, Rowley JW, Manne BK, Washington AV, Hunter-Mellado R, Tolley ND, Christensen M, Eustes AS, Montenont E, Bhatlekar S, Ventrone CH, Kirkpatrick BD, Pierce KK, Whitehead SS, Diehl SA, Bray PF, Zimmerman GA, Kosaka Y, Bozza PT, Bozza FA, Weyrich AS, Rondina MT. Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3. Blood. 2019;133(19):2013-26. Epub 20190205. doi: 10.1182/blood-2018-09-873984. PubMed PMID: 30723081; PMCID: PMC6509546.
24. Real F, Capron C, Sennepin A, Arrigucci R, Zhu A, Sannier G, Zheng J, Xu L, Masse JM, Greffe S, Cazabat M, Donoso M, Delobel P, Izopet J, Eugenin E, Gennaro ML, Rouveix E, Cramer Borde E, Bomsel M. Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4(+) T cell recovery can harbor replication-competent HIV despite viral suppression. Sci Transl Med. 2020;12(535). doi: 10.1126/scitranslmed.aat6263. PubMed PMID: 32188724.
25. Vogt MB, Lahon A, Arya RP, Spencer Clinton JL, Rico-Hesse R. Dengue viruses infect human megakaryocytes, with probable clinical consequences. PLoS Negl Trop Dis. 2019;13(11):e0007837. Epub 20191125. doi: 10.1371/journal.pntd.0007837. PubMed PMID: 31765380; PMCID: PMC6901235.
26. Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, Zhang S, Fan Z, Dong J, Yuan Z, Ding Z, Zhang Y, Hu L. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120. Epub 20200904. doi: 10.1186/s13045-020-00954-7. PubMed PMID: 32887634; PMCID: PMC7471641.
27. Shen S, Zhang J, Fang Y, Lu S, Wu J, Zheng X, Deng F. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism. J Hematol Oncol. 2021;14(1):72. Epub 20210429. doi: 10.1186/s13045-021-01082-6. PubMed PMID: 33926500; PMCID: PMC8082485.
28. Carnevale R, Cammisotto V, Bartimoccia S, Nocella C, Castellani V, Bufano M, Loffredo L, Sciarretta S, Frati G, Coluccia A, Silvestri R, Ceccarelli G, Oliva A, Venditti M, Pugliese F, Maria Mastroianni C, Turriziani O, Leopizzi M, D’Amati G, Pignatelli P, Violi F. Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection. Circ Res. 2023;132(3):290-305. Epub 20230113. doi: 10.1161/CIRCRESAHA.122.321541. PubMed PMID: 36636919.
29. Singh A, Bisht P, Bhattacharya S, Guchhait P. Role of Platelet Cytokines in Dengue Virus Infection. Front Cell Infect Microbiol. 2020;10:561366. Epub 20200930. doi: 10.3389/fcimb.2020.561366. PubMed PMID: 33102253; PMCID: PMC7554584.
30. Lumadue JA, Lanzkron SM, Kennedy SD, Kuhl DT, Kickler TS. Cytokine induction of platelet activation. Am J Clin Pathol. 1996;106(6):795-8. doi: 10.1093/ajcp/106.6.795. PubMed PMID: 8980357.
31. Rovito R, Augello M, Ben-Haim A, Bono V, d’Arminio Monforte A, Marchetti G. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors. Front Immunol. 2022;13:912336. Epub 20220610. doi: 10.3389/fimmu.2022.912336. PubMed PMID: 35757770; PMCID: PMC9231592.
32. Michelson AD. Methods for the measurement of platelet function. Am J Cardiol. 2009;103 (3 Suppl):20A-6A. doi: 10.1016/j.amjcard.2008.11.019. PubMed PMID: 19166709.
33. Hogan CA, Stevens BA, Sahoo MK, Huang C, Garamani N, Gombar S, Yamamoto F, Murugesan K, Kurzer J, Zehnder J, Pinsky BA. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Clin Infect Dis. 2021;72(9):e291-e5. doi: 10.1093/cid/ciaa1054. PubMed PMID: 32965474; PMCID: PMC7543277.
34.Rovito R, Bono V, Coianiz N, Cazzetta V, Franzese S, Mikulak J, Di Vito C, Bai F, Beaudoin-Bussières G, Tauzin A, Augello M, Tincati C, Santoro A, Borghi E, Marozin S, Finzi A, Della Bella S, Mavilio D, Marchetti G; EuCare Study Group. Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms. Commun Med (Lond). 2025 May 5;5(1):155. doi: 10.1038/s43856-025-00832-8. PMID: 40325175; PMCID: PMC12052991.
35. Maione F, Cicala C, Liverani E, Mascolo N, Perretti M, D’Acquisto F. IL-17A increases ADP-induced platelet aggregation. Biochem Biophys Res Commun. 2011;408(4):658-62. Epub 20110422. doi: 10.1016/j.bbrc.2011.04.080. PubMed PMID: 21530487; PMCID: PMC3182527.
36. Canzano P, Brambilla M, Porro B, Cosentino N, Tortorici E, Vicini S, Poggio P, Cascella A, Pengo MF, Veglia F, Fiorelli S, Bonomi A, Cavalca V, Trabattoni D, Andreini D, Omodeo Sale E, Parati G, Tremoli E, Camera M. Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients. JACC Basic Transl Sci. 2021;6(3):202-18. Epub 20210224. doi: 10.1016/j.jacbts.2020.12.009. PubMed PMID: 33649738; PMCID: PMC7904280.
37. Marino M, Scuderi F, Ponte E, Maiuri MT, De Cristofaro R, Provenzano C, Rose-John S, Cittadini A, Bartoccioni E. Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets. J Biol Regul Homeost Agents. 2013;27(3):841-52. PubMed PMID: 24152848.
38. Tosato G, Jones KD. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood. 1990;75(6):1305-10. PubMed PMID: 2310829.
39. Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191:148-50. Epub 20200430. doi: 10.1016/j.thromres.2020.04.041. PubMed PMID: 32381264; PMCID: PMC7192101.
40. Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S, Long D, Yu L. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020;31(4):490-6. Epub 20200416. doi: 10.1080/09537104.2020.1754383. PubMed PMID: 32297540; PMCID: PMC7171387.
41. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S, Humanitas C-TF. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9-14. Epub 20200423. doi: 10.1016/j.thromres.2020.04.024. PubMed PMID: 32353746; PMCID: PMC7177070.
42. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angles-Cano E, Sattler L, Mertes PM, Meziani F, Group CT. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089-98. Epub 20200504. doi: 10.1007/s00134-020-06062-x. PubMed PMID: 32367170; PMCID: PMC7197634.
43. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-4. Epub 20200506. doi: 10.1111/jth.14830. PubMed PMID: 32271988; PMCID: PMC7262324.